Hikma’s US subsidiary ... a generic version of GSK’s Advair/Seretide (fluticasone+salmeterol), and VR506, a generic, inhaled monotherapy for asthma. Vectura earlier this year merged with ...
Hikma's filing for a generic version of GlaxoSmithKline's Advair Diskus has been accepted by the FDA. The abbreviated new drug application (ANDA) for the fluticasone propionate and salmeterol ...
Objective: To test the hypothesis that once-daily treatment with fluticasone propionate is as effective as twice-daily treatment in children with well controlled asthma. Design: Multicentre ...